Amphastar Pharmaceuticals IncAMPH
Price$25.81Intrinsic value$28.4910% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $730M-0.3% YoYTTM through 30 Jun 2026
Net Income $78.5M-50.8% YoYTTM through 30 Jun 2026
Free Cash Flow $152.9MTTM through 30 Jun 2026

Margins

Current
Gross Margin41.1%
EBITDA Margin23.6%
Operating Margin7.9%
Net Margin10.8%

Returns

0.8%ROE
0.4%ROA
6.7%ROIC

Balance Sheet Health

Debt / Equity0.80x
Current Ratio3.85x
Net Debt$440.5M
Cash & Equivalents$223.6M

Quality Metrics

Altman Z-Score2.09
Piotroski F-Score5 / 9
FCF Margin20.9%
Rule of 4023.4
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $719.9M
Diluted EPS$1.69TTM
'19'20'21'22'23'24'25
FY2025: $2.03

Dividend

No dividend

Capital Allocation

R&D Spend$94.6M
Capex Intensity4.3%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.